CV Sciences (CVSI) Receivables - Other (2013 - 2023)
CV Sciences (CVSI) reported Receivables - Other of $6.4 million for Q1 2023, little changed on a YoY basis from $6.4 million in Q1 2022, and little changed sequentially from $6.4 million in Q4 2022.
CV Sciences (CVSI) Receivables - Other (2013 - 2023) Analysis & Trends
CV Sciences (CVSI) has 9 years of Receivables - Other data on file, last reported at $6.4 million in Q1 2023.
- For the quarter ending Q1 2023, Receivables - Other changed 0.0% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2023 stood at $6.4 million (changed 0.0% YoY), and the FY2022 full-year result was $6.4 million, up 2033.33% from the prior year.
- Receivables - Other was little changed at $6.4 million in Q1 2023, from $6.4 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $6.4 million in Q3 2019 to a low of $300000.0 in Q4 2021.
- A 5-year average of $5.9 million and a median of $6.4 million in 2019 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other sank 95.31% in 2021 and soared 2033.33% in 2022, its largest moves.
- Tracing CVSI's Receivables - Other over 5 years: stood at $6.4 million in 2019, then changed by 0.0% to $6.4 million in 2020, then slumped by 95.31% to $300000.0 in 2021, then soared by 2033.33% to $6.4 million in 2022, then changed by 0.0% to $6.4 million in 2023.
- Business Quant data shows CVSI's Receivables - Other at $6.4 million in Q1 2023, $6.4 million in Q4 2022, and $6.4 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 6.40 Mn |
| Mar 31, 2023 | 6.40 Mn |
| Dec 31, 2022 | 6.40 Mn |
| Dec 31, 2022 | 6.40 Mn |
| Sep 30, 2022 | 6.40 Mn |
| Sep 30, 2022 | 6.40 Mn |
| Jun 30, 2022 | 6.40 Mn |
| Jun 30, 2022 | 6.40 Mn |
| Mar 31, 2022 | 6.40 Mn |
| Mar 31, 2022 | 6.40 Mn |
| Dec 31, 2021 | 300,000.00 |
| Dec 31, 2021 | 300,000.00 |
| Sep 30, 2021 | 6.40 Mn |
| Sep 30, 2021 | 6.40 Mn |
| Jun 30, 2021 | 6.40 Mn |
| Jun 30, 2021 | 6.40 Mn |
| Mar 31, 2021 | 6.40 Mn |
| Mar 31, 2021 | 6.40 Mn |
| Dec 31, 2020 | 6.40 Mn |
| Dec 31, 2020 | 6.40 Mn |